[Experimental and clinical investigations on the inhibition of secretion of the major salivary glands with botulinum toxin A].
HNO-Klinik der Georg-August-Universität Göttingen. ellies@web.de
M
M
Ellies
D000110:Acetylcholinesterase / Q000502:physiology; D000818:Animals; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage*; D002800:Cholinesterase Inhibitors / Q000008:administration & dosage*; D006801:Humans; D007267:Injections; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors / Q000502:physiology; D052248:Nitric Oxide Synthase Type I; D010306:Parotid Gland / Q000187:drug effects* / Q000473:pathology / Q000503:physiopathology; D051381:Rats; D012463:Saliva / Q000187:drug effects / Q000201:enzymology; D012471:Salivary Proteins and Peptides / Q000378:metabolism; D012472:Salivation / Q000187:drug effects* / Q000502:physiology; D012798:Sialorrhea / Q000188:drug therapy* / Q000503:physiopathology; D013363:Submandibular Gland / Q000187:drug effects* / Q000473:pathology / Q000503:physiopathology; D016896:Treatment Outcome
D002800:Cholinesterase Inhibitors; D012471:Salivary Proteins and Peptides; C496320:NOS1 protein, human; D019001:Nitric Oxide Synthase; D052248:Nitric Oxide Synthase Type I; C496322:Nos1 protein, rat; D000110:Acetylcholinesterase; D019274:Botulinum Toxins, Type A